Koninklijke DSM NV Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Koninklijke DSM are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Koninklijke DSM NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Koninklijke DSM is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 871 M | |
| Total Cashflows From Investing Activities | 208 M |
Koninklijke |
Koninklijke DSM Relative Risk vs. Return Landscape
If you would invest (100.00) in Koninklijke DSM NV on January 24, 2024 and sell it today you would earn a total of 100.00 from holding Koninklijke DSM NV or generate -100.0% return on investment over 90 days. Koninklijke DSM NV is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Koninklijke, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Koninklijke DSM Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Koninklijke DSM's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Koninklijke DSM NV, and traders can use it to determine the average amount a Koninklijke DSM's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RDSMY |
Based on monthly moving average Koninklijke DSM is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Koninklijke DSM by adding Koninklijke DSM to a well-diversified portfolio.
Koninklijke DSM Fundamentals Growth
Koninklijke OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Koninklijke DSM, and Koninklijke DSM fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Koninklijke OTC Stock performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 24.43 B | |||
| Shares Outstanding | 691.88 M | |||
| Price To Earning | 38.86 X | |||
| Price To Book | 2.36 X | |||
| Price To Sales | 2.39 X | |||
| Revenue | 9.2 B | |||
| EBITDA | 1.71 B | |||
| Cash And Equivalents | 1.63 B | |||
| Cash Per Share | 2.36 X | |||
| Total Debt | 2.84 B | |||
| Debt To Equity | 0.31 % | |||
| Book Value Per Share | 14.09 X | |||
| Cash Flow From Operations | 1.43 B | |||
| Earnings Per Share | 1.59 X | |||
| Total Asset | 16.01 B | |||
Things to note about Koninklijke DSM NV performance evaluation
Checking the ongoing alerts about Koninklijke DSM for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Koninklijke DSM NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Koninklijke DSM NV is not yet fully synchronised with the market data | |
| Koninklijke DSM NV has some characteristics of a very speculative penny stock | |
| Koninklijke DSM NV has a very high chance of going through financial distress in the upcoming years |
- Analyzing Koninklijke DSM's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Koninklijke DSM's stock is overvalued or undervalued compared to its peers.
- Examining Koninklijke DSM's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Koninklijke DSM's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Koninklijke DSM's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Koninklijke DSM's otc stock. These opinions can provide insight into Koninklijke DSM's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Koninklijke OTC Stock
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |